Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI)	Critical Illness, Disease Attributes, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome	Recruiting	Phase 1	2026-03-03		NCT05453695

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Canadian Institutes of Health Research (CIHR)	339
McMaster University	202

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hamilton Health Sciences	Hamilton	Canada	1

Clinical trials